Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Receivables (2017 - 2025)

Historic Receivables for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to $912000.0.

  • Assembly Biosciences' Receivables changed N/A to $912000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $912000.0, marking a year-over-year change of. This contributed to the annual value of $43000.0 for FY2023, which is 9544.49% down from last year.
  • As of Q3 2025, Assembly Biosciences' Receivables stood at $912000.0.
  • In the past 5 years, Assembly Biosciences' Receivables registered a high of $1.2 million during Q3 2022, and its lowest value of $43000.0 during Q4 2023.
  • Its 5-year average for Receivables is $530692.3, with a median of $523000.0 in 2022.
  • As far as peak fluctuations go, Assembly Biosciences' Receivables surged by 18095.24% in 2022, and later tumbled by 9544.49% in 2023.
  • Assembly Biosciences' Receivables (Quarter) stood at $336000.0 in 2021, then skyrocketed by 180.95% to $944000.0 in 2022, then crashed by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then soared by 2020.93% to $912000.0 in 2025.
  • Its Receivables stands at $912000.0 for Q3 2025, versus $43000.0 for Q1 2024 and $43000.0 for Q4 2023.